HomeFATE • NASDAQ
add
Fate Therapeutics Inc
Previous close
$1.33
Day range
$1.29 - $1.38
Year range
$0.66 - $1.94
Market cap
149.98M USD
Avg Volume
1.66M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.37M | -26.40% |
Operating expense | 25.50M | -19.66% |
Net income | -32.37M | 37.92% |
Net profit margin | -2.36K | 15.66% |
Earnings per share | -0.27 | 38.64% |
EBITDA | -30.56M | 27.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 203.66M | -27.02% |
Total assets | 318.94M | -27.63% |
Total liabilities | 111.75M | -8.38% |
Total equity | 207.18M | — |
Shares outstanding | 116.26M | — |
Price to book | 0.74 | — |
Return on assets | -25.37% | — |
Return on capital | -28.09% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -32.37M | 37.92% |
Cash from operations | -23.31M | 16.13% |
Cash from investing | 27.63M | 21.10% |
Cash from financing | 1.69M | -46.01% |
Net change in cash | 6.01M | 424.12% |
Free cash flow | -4.68M | 67.56% |
About
Founded
2007
Website
Employees
161
